Cell and Gene Therapy Manufacturing Services Market
Cell and Gene Therapy Manufacturing Services Market
Report Includes
- An overview of the global market, with data for 2025, estimates for 2026 and revenue forecasts through 2031
- Analysis of cell therapy manufacturing services, including autologous and allogeneic therapies, and gene therapy services for viral and non-viral vectors
- Coverage of clinical and commercial manufacturing, including process development, vector production, cell banking and fill-finish services
- A review of indications, including oncology, cardiovascular diseases and rare diseases, and end users such as pharmaceutical and biotechnology companies and research institutes
- Discussion of outsourcing demand, growth opportunities and challenges, including production costs, workforce shortages and quality-control requirements
- Analysis of economic factors, market competition and regulatory requirements
- Insights into automation, closed-system manufacturing, AI for process optimization and patent activity
- Regional and country-level coverage of North America, Europe, Asia-Pacific, South America, and the Middle East and Africa
- Profiles of key companies, including their market shares or rankings, strategies and recent developments